Assura PLC
LSE:AGR

Watchlist Manager
Assura PLC Logo
Assura PLC
LSE:AGR
Watchlist
Price: 47.48 GBX 0.38% Market Closed
Market Cap: 1.5B GBX
Section:
 

Relative Value

The Relative Value of one AGR stock under the Base Case scenario is 76.25 GBX. Compared to the current market price of 47.48 GBX, Assura PLC is Undervalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AGR Relative Value
Base Case
76.25 GBX
Undervaluation 38%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.4
P/S
P/S
Price to Sales
8.4
vs History
52
vs Industry
17
Median 3Y
7.8
Median 5Y
8.5
Industry
3.8
Forward
8.5
More Details
9.3
P/E
P/E
Price to Earnings
9.3
vs History
63
vs Industry
22
Median 3Y
9.3
Median 5Y
9.8
Industry
16.3
Forward
13.2
More Details
14
P/OCF
P/OCF
Price to OCF
14
vs History
60
vs Industry
1
Median 3Y
13.3
Median 5Y
14.4
Industry
11.1
More Details
3.8
P/FCFE
P/FCFE
Price to FCFE
3.8
vs History
80
vs Industry
42
Median 3Y
12.5
Median 5Y
6.1
Industry
12.8
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
28
vs Industry
38
Median 3Y
0.8
Median 5Y
0.8
Industry
0.9
More Details
16.1
EV/S
EV/S
Enterprise Value to Sales
16.1
vs History
61
vs Industry
8
Median 3Y
16
Median 5Y
16.5
Industry
6.8
Forward
16.2
More Details
17.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
17.7
vs History
58
vs Industry
19
Median 3Y
17.6
Median 5Y
18
Industry
12.5
More Details
19.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.4
vs History
61
vs Industry
20
Median 3Y
19.4
Median 5Y
19.8
Industry
15.8
Forward
19.8
More Details
19.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.5
vs History
61
vs Industry
29
Median 3Y
19.4
Median 5Y
19.8
Industry
19.1
Forward
21.4
More Details
26.8
EV/OCF
EV/OCF
Enterprise Value to OCF
26.8
vs History
49
vs Industry
1
Median 3Y
25.9
Median 5Y
26.8
Industry
18.4
More Details
26.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
26.9
vs History
49
vs Industry
1
Median 3Y
25.9
Median 5Y
26.9
Industry
20.5
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
31
vs Industry
26
Median 3Y
0.9
Median 5Y
0.9
Industry
0.8
More Details

Multiples Across Competitors

AGR Competitors Multiples
Assura PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Assura PLC
LSE:AGR
1.5B GBP 8.4 9.3 19.4 19.5
US
Welltower Inc
NYSE:WELL
127.3B USD 12.8 132.5 37.7 84.5
US
Ventas Inc
NYSE:VTR
37.1B USD 6.7 156 21.9 53.6
US
Omega Healthcare Investors Inc
NYSE:OHI
13B USD 11.3 24.9 16.6 24
US
Healthpeak Properties Inc
F:HC5
9.5B EUR 4 -284.4 12.7 39.5
US
Physicians Realty Trust
NYSE:DOC
11.1B USD 4 -285.4 12.8 39.6
US
CareTrust REIT Inc
NYSE:CTRE
8.1B USD 18.9 31 22.6 29
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 8 66 20 51.5
US
Healthcare Realty Trust Inc
NYSE:HR
5.9B USD 4.9 -16 15.9 170.1
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4.7B USD 6.3 26.6 15.9 26.4
US
National Health Investors Inc
NYSE:NHI
3.7B USD 10.4 25.2 17.8 25.2
P/E Multiple
Earnings Growth PEG
UK
Assura PLC
LSE:AGR
Average P/E: 59
9.3
N/A N/A
US
Welltower Inc
NYSE:WELL
132.5
29%
4.6
US
Ventas Inc
NYSE:VTR
156
79%
2
US
Omega Healthcare Investors Inc
NYSE:OHI
24.9
12%
2.1
US
H
Healthpeak Properties Inc
F:HC5
Negative Multiple: -284.4
-7%
N/A
US
Physicians Realty Trust
NYSE:DOC
Negative Multiple: -285.4
-7%
N/A
US
C
CareTrust REIT Inc
NYSE:CTRE
31
44%
0.7
US
H
Healthcare Trust Of America Inc
F:HT01
66
N/A N/A
US
Healthcare Realty Trust Inc
NYSE:HR
Negative Multiple: -16 N/A N/A
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
26.6
18%
1.5
US
National Health Investors Inc
NYSE:NHI
25.2
6%
4.2

See Also

Summary
AGR intrinsic value, competitors valuation, and company profile.
DCF Valuation
AGR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AGR stock valuation using valuation multiples.
Wall Street Estimates
AGR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AGR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 304,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.